Organicell Regenerative Medicine, Inc.
OCEL · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,215 | $12,441 | $30,944 | $57,742 |
| - Cash | $657 | $1,756 | $3,753 | $109 |
| + Debt | $13 | $693 | $1,038 | $827 |
| Enterprise Value | $10,571 | $11,378 | $28,229 | $58,461 |
| Revenue | $4,620 | $4,558 | $6,491 | $5,597 |
| % Growth | 1.4% | -29.8% | 16% | – |
| Gross Profit | $3,776 | $4,051 | $5,737 | $5,050 |
| % Margin | 81.7% | 88.9% | 88.4% | 90.2% |
| EBITDA | -$5,319 | -$6,069 | -$8,166 | -$12,666 |
| % Margin | -115.1% | -133.1% | -125.8% | -226.3% |
| Net Income | -$4,705 | -$6,987 | -$8,950 | -$12,820 |
| % Margin | -101.8% | -153.3% | -137.9% | -229% |
| EPS Diluted | -0.74 | -0.99 | -1.57 | -2.42 |
| % Growth | 25.3% | 36.9% | 35.1% | – |
| Operating Cash Flow | -$1,450 | -$2,197 | -$3,166 | -$2,609 |
| Capital Expenditures | $0 | -$25 | -$825 | -$496 |
| Free Cash Flow | -$1,450 | -$2,223 | -$3,991 | -$3,105 |